V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20222326 | 20169106 | 0 | null | null | 2016-10-12 | 2016-11-09 | LENVATINIB | 02 | null | LENVATINIB | 101263238 |
| 20222329 | 20169107 | 0 | null | null | 2018-05-10 | 2018-05-13 | LANREOTIDE | null | null | LANREOTIDE | 100678597 |
| 20222331 | 20169108 | 0 | 66.3 | null | 2019-01-06 | 2019-08-15 | LANREOTIDE | 02 | null | LANREOTIDE | 101370002 |
| 20222424 | 20169110 | 0 | null | Palliative (P) | 2016-11-01 | 2018-12-31 | null | 02 | null | FLUOROURACIL + MITOMYCIN | 100593268 |
| 20222456 | 20169112 | 0 | null | Adjuvant (A) | 2018-01-08 | 2018-01-08 | null | 02 | N | HCX | 101175189 |
| 20222486 | 20169113 | 0 | 81.2 | null | 2018-08-14 | 2019-11-23 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101755887 |
| 20222603 | 20169115 | 0 | 71 | Adjuvant (A) | 2016-04-02 | 2017-01-07 | null | 02 | Y | CAPECITABINE + MITOMYCIN | 101233359 |
| 20222618 | 20169116 | 0 | 101.3 | null | null | 2018-03-14 | Capecitabine + Mitomycin | 02 | null | CAPECITABINE + MITOMYCIN | 101200000 |
| 20222654 | 20169118 | 0 | 68.8 | Palliative (P) | 2018-07-25 | 2018-07-25 | null | 02 | Y | LENVATINIB | 100929539 |
| 20222684 | 20169119 | 0 | null | 03 | 2018-11-02 | 2018-11-04 | LANREOTIDE | null | N | LANREOTIDE | 101426317 |
| 20222716 | 20169120 | null | null | Palliative (P) | 2019-09-16 | 2019-09-24 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CAPECITABINE + MITOMYCIN | 101524838 |
| 20222720 | 20169121 | 0 | null | null | 2016-05-19 | 2016-05-19 | null | 02 | null | HCX | 100618403 |
| 20222746 | 20169122 | 0 | 0 | null | 2017-09-09 | 2017-10-10 | LANREOTIDE | 02 | null | LANREOTIDE | 100538492 |
| 20222787 | 20169124 | 0 | 60 | 03 | 2017-07-13 | 2017-07-21 | LENVATINIB | null | N | LENVATINIB | 101814759 |
| 20222811 | 20169127 | 0 | null | Palliative (P) | null | 2016-12-16 | null | 02 | N | CAPECITABINE + MITOMYCIN | 101581646 |
| 20222875 | 20169130 | 1.98 | 87.3 | Palliative (P) | 2015-10-04 | 2016-08-23 | Capecitabine + Mitomycin | 02 | N | CAPECITABINE + MITOMYCIN | 100581815 |
| 20222877 | 20169131 | null | null | Adjuvant (A) | null | 2019-02-03 | Capecitabine + Mitomycin | 02 | N | CAPECITABINE + MITOMYCIN | 101351080 |
| 20222906 | 20169133 | 0 | null | null | 2018-04-26 | 2018-04-28 | Cape+Cisplatin+Trastuzumab Main | 02 | null | HCX | 101095083 |
| 20222951 | 20169134 | 1.78 | 77.5 | null | null | 2020-01-17 | null | 02 | null | DOXORUBICIN EMBOLISATION | 101348673 |
| 20223028 | 20169135 | 0 | 50.4 | Palliative (P) | 2019-06-20 | 2019-07-18 | LANREOTIDE | null | N | LANREOTIDE | 101365062 |
| 20223031 | 20169136 | 0 | null | Curative (C) | 2016-11-11 | 2016-12-26 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | Y | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100271808 |
| 20223054 | 20169137 | 0 | null | Palliative (P) | 2019-08-31 | 2019-09-01 | null | 2 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100490988 |
| 20223087 | 20169138 | 0 | 102.3 | Curative (C) | 2019-03-14 | 2019-03-18 | null | 02 | Y | HCX | 100037041 |
| 20223108 | 20169140 | 0 | null | Palliative (P) | 2015-04-20 | 2016-06-04 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | HCX | 101779787 |
| 20223156 | 20169142 | 0 | 129 | null | 2019-05-07 | 2019-05-08 | null | 02 | null | CAPECITABINE + MITOMYCIN | 100097706 |
| 20223177 | 20169143 | 0 | null | 03 | 2020-06-05 | 2020-06-30 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 100651064 |
| 20223184 | 20169144 | 0 | null | Palliative (P) | 2017-12-14 | 2018-02-04 | FLUOROURACIL + MITOMYCIN | 99 | N | FLUOROURACIL + MITOMYCIN | 100270823 |
| 20223193 | 20169145 | 0 | null | null | 2019-06-23 | 2019-08-06 | null | N | null | DOXORUBICIN EMBOLISATION | 101448378 |
| 20223215 | 20169146 | 0 | 0 | null | null | 2016-12-31 | FLUOROURACIL + MITOMYCIN | 02 | null | FLUOROURACIL + MITOMYCIN | 100222135 |
| 20223272 | 20169147 | 0 | null | Palliative (P) | 2017-06-07 | 2017-08-26 | null | 02 | N | LANREOTIDE | 100588758 |
| 20223275 | 20169148 | 0 | 0 | null | 2015-06-16 | 2015-07-03 | null | 02 | null | HCX | 100629730 |
| 20223342 | 20169151 | 0 | null | Palliative (P) | 2017-01-02 | 2017-01-25 | null | 02 | Y | CAPECITABINE + MITOMYCIN | 101132155 |
| 20223351 | 20169152 | 0 | null | null | 2021-04-16 | 2021-04-25 | Capecitabine + Mitomycin | 02 | null | CAPECITABINE + MITOMYCIN | 100344915 |
| 20223359 | 20169153 | 1.61 | null | Curative (C) | 2021-10-31 | 2021-11-14 | null | N | N | DOXORUBICIN EMBOLISATION | 101719266 |
| 20223410 | 20169154 | 0 | 66 | Palliative (P) | 2017-12-18 | 2017-12-19 | LANREOTIDE | 2 | N | LANREOTIDE | 100797935 |
| 20223411 | 20169155 | 0 | null | Adjuvant (A) | 2018-07-14 | 2018-07-31 | Capecitabine + Mitomycin | 02 | N | CAPECITABINE + MITOMYCIN | 100851875 |
| 20223425 | 20169157 | 0 | 87.7 | Palliative (P) | 2018-03-12 | 2018-06-28 | null | null | N | LANREOTIDE | 100388047 |
| 20223463 | 20169159 | null | null | null | 2017-01-19 | 2017-04-14 | null | 99 | null | HCX | 100218749 |
| 20223476 | 20169160 | 0 | 117 | Palliative (P) | 2016-06-13 | 2016-12-13 | null | N | null | HCX | 100177400 |
| 20223477 | 20169161 | 0 | 58 | null | 2016-03-21 | 2016-04-03 | Capecitabine + Mitomycin | 02 | null | CAPECITABINE + MITOMYCIN | 100121290 |
| 20223478 | 20169162 | null | 64.9 | Palliative (P) | 2016-08-13 | 2016-08-19 | null | N | N | LANREOTIDE | 101139357 |
| 20223488 | 20169163 | 0 | null | null | 2017-07-05 | 2017-07-11 | null | 02 | N | LENVATINIB | 100590326 |
| 20223489 | 20169164 | 0 | 124 | null | 2019-04-04 | 2019-09-20 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | null | FLUOROURACIL + MITOMYCIN | 100094797 |
| 20223545 | 20169165 | null | 106.4 | null | null | 2017-05-18 | null | 02 | null | LENVATINIB | 101021219 |
| 20223572 | 20169166 | 0 | 59.1 | Palliative (P) | 2016-10-23 | 2016-10-23 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | FLUOROURACIL + MITOMYCIN | 100592349 |
| 20223603 | 20169168 | 0 | null | null | 2018-12-18 | 2019-03-05 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100595329 |
| 20223604 | 20169169 | 0 | 51.2 | null | 2018-06-07 | 2018-08-08 | null | 02 | null | DOXORUBICIN EMBOLISATION | 100314664 |
| 20223614 | 20169170 | 0 | null | null | 2016-10-11 | 2016-11-01 | Panitumumab +Oxaliplatin +MdG | null | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101269118 |
| 20223640 | 20169171 | 0 | 49.5 | Curative (C) | 2017-07-24 | 2017-08-06 | null | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100893618 |
| 20223653 | 20169172 | 0 | 66.4 | null | 2016-01-04 | 2016-01-05 | null | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101842318 |